EICHOR
● Suspended
Hot AXIOS™ for Bile Duct Drainage in Malignant Stenosis
Condition: Malignant Biliary Stenosis · Sponsor: Boston Scientific Corporation
About this study
The study is designed to highlight the effectiveness of the Hot AXIOS™ stent when used in accordance with standard medical practice on the evolution of the quality of life of patients with malignant biliary stenosis requiring drainage of the bile ducts after failure of ERCP, in the two months after stent placement.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (18)
| CHU de Besançon | Besançon, France | — |
| Clinique des Cedres, Ramsay Sante | Cornebarrieu, France | — |
| CHU Limoges | Limoges, France | — |
| Hopital Prive Jean Mermoz | Lyon, France | — |
| Clinique Jules Verne | Nantes, France | — |
| CHU Nice | Nice, France | — |
| Hopital Saint Antoine | Paris, France | — |
| Hopital Paris Saint-Joseph | Paris, France | — |
| Hopital Europeen Georges-Pompidou | Paris, France | — |
| CHU de Poitiers | Poitiers, France | — |
| CHU Reims | Reims, France | — |
| CHRU Hopital Pontchaillou | Rennes, France | — |
+ 6 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06750146